mortality/aging
• more than 80% of mice survive beyond 40 weeks
• mice treated with phenylhydrazine to further reduce red blood counts show an even greater improvement in survival
|
hematopoietic system
N |
• mice exhibit amelioration of the neutrophilia and thrombocytosis, partial reversion of reticulocytosis, mild reduction in red blood cell counts, fewer megakaryocytes and megakaryocyte clusters, reduced spleen size, and reversion of about 25% of the red blood cell expansion seen in single Jak2tm1.1Ble conditional mutants
• bone marrow lineage-negative hematopoietic stem and progenitor cells grown in culture show a reduction in the increased proliferation of erythroid and granulocytic cells seen in single Jak2tm1.1Ble conditional mutants
|
• granulocytic differentiation to Gr1/Mac1 double-positive cells is mildly decreased in cultured cells
|
• early-stage megakaryocytic differentiation to CD41+ cells is mildly decreased in cultured cells
|
homeostasis/metabolism
N |
• mice show decreased vascular occlusions than in single Jak2tm1.1Ble conditional mutants, with a decrease in the number of large clots with compact red blood cells and improved blood flow
|
immune system
N |
• several proinflammatory cytokines, including CCL3 and CSF1, that are increased in single Jak2tm1.1Ble conditional mutants are reduced
|
• granulocytic differentiation to Gr1/Mac1 double-positive cells is mildly decreased in cultured cells
|
cellular
• erythroid differentiation to Ter119/CD71 double-positive cells is mildly decreased in cultured cells
|
• granulocytic differentiation to Gr1/Mac1 double-positive cells is mildly decreased in cultured cells
|
• early-stage megakaryocytic differentiation to CD41+ cells is mildly decreased in cultured cells
|